Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study.
BACKGROUND:Many national cardiovascular disease (CVD) risk factor management guidelines now recommend that drug treatment decisions should be informed primarily by patients' multi-variable predicted risk of CVD, rather than on the basis of single risk factor thresholds. To investigate the poten...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5383032?pdf=render |
| _version_ | 1818940910862336000 |
|---|---|
| author | Josh Knight Susan Wells Roger Marshall Daniel Exeter Rod Jackson |
| author_facet | Josh Knight Susan Wells Roger Marshall Daniel Exeter Rod Jackson |
| author_sort | Josh Knight |
| collection | DOAJ |
| description | BACKGROUND:Many national cardiovascular disease (CVD) risk factor management guidelines now recommend that drug treatment decisions should be informed primarily by patients' multi-variable predicted risk of CVD, rather than on the basis of single risk factor thresholds. To investigate the potential impact of treatment guidelines based on CVD risk thresholds at a national level requires individual level data representing the multi-variable CVD risk factor profiles for a country's total adult population. As these data are seldom, if ever, available, we aimed to create a synthetic population, representing the joint CVD risk factor distributions of the adult New Zealand population. METHODS AND RESULTS:A synthetic population of 2,451,278 individuals, representing the actual age, gender, ethnicity and social deprivation composition of people aged 30-84 years who completed the 2013 New Zealand census was generated using Monte Carlo sampling. Each 'synthetic' person was then probabilistically assigned values of the remaining cardiovascular disease (CVD) risk factors required for predicting their CVD risk, based on data from the national census national hospitalisation and drug dispensing databases and a large regional cohort study, using Monte Carlo sampling and multiple imputation. Where possible, the synthetic population CVD risk distributions for each non-demographic risk factor were validated against independent New Zealand data sources. CONCLUSIONS:We were able to develop a synthetic national population with realistic multi-variable CVD risk characteristics. The construction of this population is the first step in the development of a micro-simulation model intended to investigate the likely impact of a range of national CVD risk management strategies that will inform CVD risk management guideline updates in New Zealand and elsewhere. |
| first_indexed | 2024-12-20T06:47:09Z |
| format | Article |
| id | doaj.art-6f794d16b1d84125846d993506de1e4b |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-20T06:47:09Z |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-6f794d16b1d84125846d993506de1e4b2022-12-21T19:49:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01124e017317010.1371/journal.pone.0173170Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study.Josh KnightSusan WellsRoger MarshallDaniel ExeterRod JacksonBACKGROUND:Many national cardiovascular disease (CVD) risk factor management guidelines now recommend that drug treatment decisions should be informed primarily by patients' multi-variable predicted risk of CVD, rather than on the basis of single risk factor thresholds. To investigate the potential impact of treatment guidelines based on CVD risk thresholds at a national level requires individual level data representing the multi-variable CVD risk factor profiles for a country's total adult population. As these data are seldom, if ever, available, we aimed to create a synthetic population, representing the joint CVD risk factor distributions of the adult New Zealand population. METHODS AND RESULTS:A synthetic population of 2,451,278 individuals, representing the actual age, gender, ethnicity and social deprivation composition of people aged 30-84 years who completed the 2013 New Zealand census was generated using Monte Carlo sampling. Each 'synthetic' person was then probabilistically assigned values of the remaining cardiovascular disease (CVD) risk factors required for predicting their CVD risk, based on data from the national census national hospitalisation and drug dispensing databases and a large regional cohort study, using Monte Carlo sampling and multiple imputation. Where possible, the synthetic population CVD risk distributions for each non-demographic risk factor were validated against independent New Zealand data sources. CONCLUSIONS:We were able to develop a synthetic national population with realistic multi-variable CVD risk characteristics. The construction of this population is the first step in the development of a micro-simulation model intended to investigate the likely impact of a range of national CVD risk management strategies that will inform CVD risk management guideline updates in New Zealand and elsewhere.http://europepmc.org/articles/PMC5383032?pdf=render |
| spellingShingle | Josh Knight Susan Wells Roger Marshall Daniel Exeter Rod Jackson Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study. PLoS ONE |
| title | Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study. |
| title_full | Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study. |
| title_fullStr | Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study. |
| title_full_unstemmed | Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study. |
| title_short | Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study. |
| title_sort | developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies a derivation and validation study |
| url | http://europepmc.org/articles/PMC5383032?pdf=render |
| work_keys_str_mv | AT joshknight developingasyntheticnationalpopulationtoinvestigatetheimpactofdifferentcardiovasculardiseaseriskmanagementstrategiesaderivationandvalidationstudy AT susanwells developingasyntheticnationalpopulationtoinvestigatetheimpactofdifferentcardiovasculardiseaseriskmanagementstrategiesaderivationandvalidationstudy AT rogermarshall developingasyntheticnationalpopulationtoinvestigatetheimpactofdifferentcardiovasculardiseaseriskmanagementstrategiesaderivationandvalidationstudy AT danielexeter developingasyntheticnationalpopulationtoinvestigatetheimpactofdifferentcardiovasculardiseaseriskmanagementstrategiesaderivationandvalidationstudy AT rodjackson developingasyntheticnationalpopulationtoinvestigatetheimpactofdifferentcardiovasculardiseaseriskmanagementstrategiesaderivationandvalidationstudy |